Drug intelligence / Profile preview

Wei's Huoxue Tongluo Granules

Development stage
Unknown
Lead developer
Beijing University of Chinese Medicine East Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Wei's Huoxue Tongluo Granules is a specialized Traditional Chinese Medicine (TCM) hospital preparation developed by the ophthalmology department of Dongfang Hospital, affiliated with the Beijing University of Chinese Medicine. Formulated based on the clinical expertise of Professor Wei Qiuping, the granules are primarily indicated for the treatment of non-arteritic anterior ischemic optic neuropathy (NAION). The therapeutic mechanism is rooted in the TCM principles of 'Huoxue Tongluo' (promoting blood circulation and dredging collaterals), which aims to improve microcirculation in the optic nerve head, reduce vascular resistance, and alleviate optic disc edema. Clinical studies have suggested that the formula helps protect retinal ganglion cells and improve visual function in patients suffering from sudden vision loss due to ischemic events in the retrobulbar tissues.

Other names
Wei Shi Huo Xue Tong Luo Ke Li魏氏活血通络颗粒

Beyond the preview

Go deeper on Wei's Huoxue Tongluo Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wei's Huoxue Tongluo Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call